Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Inguinal Hernia Repair
NCT07837492Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Oct 2026
- Primary completion
- Oct 2027
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine and nalbuphine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Time to First Rescue Analgesia at 24 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinenalbuphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07837492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07837492.